Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel

Autores
Arias, Hugo Rubén; McCardy, Elizabeth A.; Gallagher, Martín J.; Blanton, Michael P.
Año de publicación
2001
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Barbiturate-induced anesthesia is a complex mechanism that probably involves several ligand-gated ion channel superfamilies. One of these superfamilies includes the archetypical nicotinic acetylcholine receptor (nAChR), in which barbiturates act as noncompetitive antagonists. In this regard, we used the Torpedo californica nAChR and a series of barbiturate analogs to characterize the barbiturate binding site(s) on this superfamily member. [14C]Amobarbital binds to one high-affinity (Kd = 3.7 μM) and several (∼11) low-affinity (Kd = 930 μM) sites on the resting and desensitized nAChRs, respectively. Characteristics of the barbiturate binding site on the resting nAChR include: (1) a tight structure-activity relationship. For example, the barbiturate isobarbital [5-ethyl-5′-(2-methylbutyl) barbituric acid] is >10-fold less potent than its formula isomer amobarbital [5-ethyl-5′-(3-methylbutyl) barbituric acid] in inhibiting [14C]amobarbital binding. (2) A binding locus within the pore of the nAChR ion channel. Each of the barbiturate analogs inhibited the binding of [3H]tetracaine or photoincorporation of 3-trifluoromethyl-3-(m-[125I]iodophenyl) diazirine in a mutually exclusive manner. (3) Stereoselective binding. The R(+)-enantiomers of isobarbital and pentobarbital are ∼2-fold more potent in inhibiting 3-trifluoromethyl-3-(m-[125I]iodophenyl) diazirine photoincorporation than the S(−)-enantiomers. Finally, molecular modeling suggests that within the channel, the pyrimidine ring of the barbiturate is located just above the highly conserved leucine ring (M2–9; e.g., δLeu-265), whereas the 5′ side chain projects downward, and depending upon its conformation, introduces steric hindrance to binding because of the restriction in the lumen of the channel introduced by the leucine side chains.
Fil: Arias, Hugo Rubén. Texas Tech University Health Sciences Center; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: McCardy, Elizabeth A.. Texas Tech University Health Sciences Center; Estados Unidos
Fil: Gallagher, Martín J.. University of Washington; Estados Unidos
Fil: Blanton, Michael P.. Texas Tech University Health Sciences Center; Estados Unidos
Materia
Nicotinic Acetylcholine Receptor
Barbiturates
Photoaffinity Labeling
Radioligand Binding
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/78778

id CONICETDig_4fa567bcaa7895d2f3a69408a9293c17
oai_identifier_str oai:ri.conicet.gov.ar:11336/78778
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion ChannelArias, Hugo RubénMcCardy, Elizabeth A.Gallagher, Martín J.Blanton, Michael P.Nicotinic Acetylcholine ReceptorBarbituratesPhotoaffinity LabelingRadioligand Bindinghttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Barbiturate-induced anesthesia is a complex mechanism that probably involves several ligand-gated ion channel superfamilies. One of these superfamilies includes the archetypical nicotinic acetylcholine receptor (nAChR), in which barbiturates act as noncompetitive antagonists. In this regard, we used the Torpedo californica nAChR and a series of barbiturate analogs to characterize the barbiturate binding site(s) on this superfamily member. [14C]Amobarbital binds to one high-affinity (Kd = 3.7 μM) and several (∼11) low-affinity (Kd = 930 μM) sites on the resting and desensitized nAChRs, respectively. Characteristics of the barbiturate binding site on the resting nAChR include: (1) a tight structure-activity relationship. For example, the barbiturate isobarbital [5-ethyl-5′-(2-methylbutyl) barbituric acid] is >10-fold less potent than its formula isomer amobarbital [5-ethyl-5′-(3-methylbutyl) barbituric acid] in inhibiting [14C]amobarbital binding. (2) A binding locus within the pore of the nAChR ion channel. Each of the barbiturate analogs inhibited the binding of [3H]tetracaine or photoincorporation of 3-trifluoromethyl-3-(m-[125I]iodophenyl) diazirine in a mutually exclusive manner. (3) Stereoselective binding. The R(+)-enantiomers of isobarbital and pentobarbital are ∼2-fold more potent in inhibiting 3-trifluoromethyl-3-(m-[125I]iodophenyl) diazirine photoincorporation than the S(−)-enantiomers. Finally, molecular modeling suggests that within the channel, the pyrimidine ring of the barbiturate is located just above the highly conserved leucine ring (M2–9; e.g., δLeu-265), whereas the 5′ side chain projects downward, and depending upon its conformation, introduces steric hindrance to binding because of the restriction in the lumen of the channel introduced by the leucine side chains.Fil: Arias, Hugo Rubén. Texas Tech University Health Sciences Center; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: McCardy, Elizabeth A.. Texas Tech University Health Sciences Center; Estados UnidosFil: Gallagher, Martín J.. University of Washington; Estados UnidosFil: Blanton, Michael P.. Texas Tech University Health Sciences Center; Estados UnidosAmerican Society for Pharmacology and Experimental Therapeutics2001-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/78778Arias, Hugo Rubén; McCardy, Elizabeth A.; Gallagher, Martín J.; Blanton, Michael P.; Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel; American Society for Pharmacology and Experimental Therapeutics; Molecular Pharmacology; 60; 3; 9-2001; 497-5060026-895XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://molpharm.aspetjournals.org/content/60/3/497.longinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:56:22Zoai:ri.conicet.gov.ar:11336/78778instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:56:23.025CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel
title Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel
spellingShingle Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel
Arias, Hugo Rubén
Nicotinic Acetylcholine Receptor
Barbiturates
Photoaffinity Labeling
Radioligand Binding
title_short Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel
title_full Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel
title_fullStr Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel
title_full_unstemmed Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel
title_sort Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel
dc.creator.none.fl_str_mv Arias, Hugo Rubén
McCardy, Elizabeth A.
Gallagher, Martín J.
Blanton, Michael P.
author Arias, Hugo Rubén
author_facet Arias, Hugo Rubén
McCardy, Elizabeth A.
Gallagher, Martín J.
Blanton, Michael P.
author_role author
author2 McCardy, Elizabeth A.
Gallagher, Martín J.
Blanton, Michael P.
author2_role author
author
author
dc.subject.none.fl_str_mv Nicotinic Acetylcholine Receptor
Barbiturates
Photoaffinity Labeling
Radioligand Binding
topic Nicotinic Acetylcholine Receptor
Barbiturates
Photoaffinity Labeling
Radioligand Binding
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Barbiturate-induced anesthesia is a complex mechanism that probably involves several ligand-gated ion channel superfamilies. One of these superfamilies includes the archetypical nicotinic acetylcholine receptor (nAChR), in which barbiturates act as noncompetitive antagonists. In this regard, we used the Torpedo californica nAChR and a series of barbiturate analogs to characterize the barbiturate binding site(s) on this superfamily member. [14C]Amobarbital binds to one high-affinity (Kd = 3.7 μM) and several (∼11) low-affinity (Kd = 930 μM) sites on the resting and desensitized nAChRs, respectively. Characteristics of the barbiturate binding site on the resting nAChR include: (1) a tight structure-activity relationship. For example, the barbiturate isobarbital [5-ethyl-5′-(2-methylbutyl) barbituric acid] is >10-fold less potent than its formula isomer amobarbital [5-ethyl-5′-(3-methylbutyl) barbituric acid] in inhibiting [14C]amobarbital binding. (2) A binding locus within the pore of the nAChR ion channel. Each of the barbiturate analogs inhibited the binding of [3H]tetracaine or photoincorporation of 3-trifluoromethyl-3-(m-[125I]iodophenyl) diazirine in a mutually exclusive manner. (3) Stereoselective binding. The R(+)-enantiomers of isobarbital and pentobarbital are ∼2-fold more potent in inhibiting 3-trifluoromethyl-3-(m-[125I]iodophenyl) diazirine photoincorporation than the S(−)-enantiomers. Finally, molecular modeling suggests that within the channel, the pyrimidine ring of the barbiturate is located just above the highly conserved leucine ring (M2–9; e.g., δLeu-265), whereas the 5′ side chain projects downward, and depending upon its conformation, introduces steric hindrance to binding because of the restriction in the lumen of the channel introduced by the leucine side chains.
Fil: Arias, Hugo Rubén. Texas Tech University Health Sciences Center; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: McCardy, Elizabeth A.. Texas Tech University Health Sciences Center; Estados Unidos
Fil: Gallagher, Martín J.. University of Washington; Estados Unidos
Fil: Blanton, Michael P.. Texas Tech University Health Sciences Center; Estados Unidos
description Barbiturate-induced anesthesia is a complex mechanism that probably involves several ligand-gated ion channel superfamilies. One of these superfamilies includes the archetypical nicotinic acetylcholine receptor (nAChR), in which barbiturates act as noncompetitive antagonists. In this regard, we used the Torpedo californica nAChR and a series of barbiturate analogs to characterize the barbiturate binding site(s) on this superfamily member. [14C]Amobarbital binds to one high-affinity (Kd = 3.7 μM) and several (∼11) low-affinity (Kd = 930 μM) sites on the resting and desensitized nAChRs, respectively. Characteristics of the barbiturate binding site on the resting nAChR include: (1) a tight structure-activity relationship. For example, the barbiturate isobarbital [5-ethyl-5′-(2-methylbutyl) barbituric acid] is >10-fold less potent than its formula isomer amobarbital [5-ethyl-5′-(3-methylbutyl) barbituric acid] in inhibiting [14C]amobarbital binding. (2) A binding locus within the pore of the nAChR ion channel. Each of the barbiturate analogs inhibited the binding of [3H]tetracaine or photoincorporation of 3-trifluoromethyl-3-(m-[125I]iodophenyl) diazirine in a mutually exclusive manner. (3) Stereoselective binding. The R(+)-enantiomers of isobarbital and pentobarbital are ∼2-fold more potent in inhibiting 3-trifluoromethyl-3-(m-[125I]iodophenyl) diazirine photoincorporation than the S(−)-enantiomers. Finally, molecular modeling suggests that within the channel, the pyrimidine ring of the barbiturate is located just above the highly conserved leucine ring (M2–9; e.g., δLeu-265), whereas the 5′ side chain projects downward, and depending upon its conformation, introduces steric hindrance to binding because of the restriction in the lumen of the channel introduced by the leucine side chains.
publishDate 2001
dc.date.none.fl_str_mv 2001-09
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/78778
Arias, Hugo Rubén; McCardy, Elizabeth A.; Gallagher, Martín J.; Blanton, Michael P.; Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel; American Society for Pharmacology and Experimental Therapeutics; Molecular Pharmacology; 60; 3; 9-2001; 497-506
0026-895X
CONICET Digital
CONICET
url http://hdl.handle.net/11336/78778
identifier_str_mv Arias, Hugo Rubén; McCardy, Elizabeth A.; Gallagher, Martín J.; Blanton, Michael P.; Interaction of Barbiturate Analogs with the Torpedo californica Nicotinic Acetylcholine Receptor Ion Channel; American Society for Pharmacology and Experimental Therapeutics; Molecular Pharmacology; 60; 3; 9-2001; 497-506
0026-895X
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://molpharm.aspetjournals.org/content/60/3/497.long
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv American Society for Pharmacology and Experimental Therapeutics
publisher.none.fl_str_mv American Society for Pharmacology and Experimental Therapeutics
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269401403883520
score 13.13397